Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

New glucocorticosteroids prepared and tested at GSK

June 11, 2004

Orphan drug designation for Thymosin beta4 for epidermolysis bullosa

June 11, 2004

Leptin accelerates wound angiogenesis in vivo

June 7, 2004

Effective wound healing by topical application of novel preclinical therapeutic peptides

June 7, 2004

Topical vitamin B12 reported safe and effective in atopic dermatitis

June 4, 2004

Enrollment under way in confirmatory phase III trial of Sebazole

June 1, 2004

Nadixa launched in Germany

May 26, 2004

Zimycan receives approval in Belgium for treatment of diaper dermatitis

May 25, 2004

IDEA-070 shows excellent efficacy in treatment of UVB-induced skin inflammation

May 21, 2004

Further data on alefacept in the treatment of psoriasis

May 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...